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migration, some issues still provide
significant hurdles that are only just
beginning to be overcome.
Complex cell behaviors, such as
migration, result from coordinated
activity of several individual
component processes. While
considerable progress has been
made in identifying molecules
related to migration and elucidating
the mechanisms by which they
function in a component process,
understanding the integration of
these various component
processes presents a major
challenge. Fortunately,
technologies are emerging that
allow us to study the spatial and
temporal regulation that generates
the coordination of these
processes. These include
biosensors that allow spatially
resolved assays of signaling events
in real time in living cells and
photomanipulative techniques that
allow local perturbations of
function via photoactivation or
inactivation to complement the
observations made using
biosensors. It is now clear that
migration in vivo differs from that
studied in vitro; this may reflect
different signaling mechanisms or
cellular mechanics. The
development of three-dimensional
systems that allow imaging of
cellular and molecular dynamics is
helping to reveal mechanisms
underlying migration in physio-
logical environments. Finally, the
signals that initiate, guide, and stop
migration are not well understood,
especially in the context of the
component processes of migration
and their regulation.
Cell Migration as a Discipline
Until recently, research in cell
migration was split into a number
of subdisciplines that did not
interact as an integrated research
area. Over the past few years, cell
migration has emerged as its own
discipline. 
Recently, an NIH-sponsored Cell
Migration Consortium was formed
(www.cellmigration.org) with the
aim of promoting migration
research by addressing some
major barriers to progress in the
field. These include a census of the
migration proteome, the structure
of the supramolecular complexes
that drive migration, development
of novel signaling reagents that
report spatially resolved signals in
living cells, development of
mathematical models of migration,
development of novel imaging
techniques, development of new
biomaterials, and the production of
knockout, knockin and knockdown
mice and cell lines. Other
Consortium activities include
promoting interdisciplinary
collaboration and organizing
information in the field through a
web-based cell migration
knowledge database.
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Q & A
John Gurdon
John Gurdon is at the Wellcome
Trust/Cancer Research UK
Institute of Cancer and
Developmental Biology in
Cambridge. Educated at Eton
and Christ Church, Oxford, he
changed from classics to
zoology. During graduate work
under Michael Fischberg at
Oxford, he was the first to obtain
a normal adult animal by somatic
cell nuclear transfer. He then
spent a year on bacteriophage
genetics at CalTech. From a
lectureship at Oxford, he moved
in mid-career first to the MRC
Molecular Biology Laboratory in
Cambridge and then, in 1983, to
the University’s Zoology
Department under Sir Gabriel
Horn. In 1990 he co-founded,
with Ron Laskey, the Wellcome
Trust/Cancer Research
Campaign Institute in Cambridge.
His scientific work has never
strayed from the use of Xenopus,
and has concentrated on aspects
of cell differentiation, including
nuclear reprogramming,
morphogen gradients and the
community effect. He has always
remained active in doing his own
experiments with his own hands,
trusting that members of his
group are clever enough to
largely guide and execute their
own experiments.
How did you come to have a
career in science? Not easily.
After one term of biology at
school, the teacher wrote “For
Gurdon to continue in biology
would be a complete waste of
time both for him and for those
who would have to teach him”. I
studied classics, took the Oxford
entrance exam in this subject,
and was offered a place on
condition that I did not read
classics. Luckily for me, they
were short of applicants at that
time. My kind parents paid for an
extra year’s private teaching to
enable me to start the zoology
course at Oxford.
Do you have heroes? Rodney
Magazine
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Porter was head of a large and
successful biochemistry
department at Oxford, and did
outstanding research. I was
neither in his department nor his
research field (immunology), but
he nevertheless made time and
had the inclination to follow my
research and promote it in
numerous directions. In
administration, his philosophy
was to spot trouble before it
really happened; otherwise he
didn’t interfere. Max Perutz was
responsible for my moving to
Cambridge from Oxford. He
initiated and led the most
successful scientific institute in
history. When in the canteen, he
was always available to everyone
and kept administration down to
(or below) the perceived
minimum — but it worked
brilliantly — his unobtrusive
leadership is a lesson to all of us.
In my field, I was much
influenced by Jean Brachet
(Brussels) whose Biochemical
Cytology (1957) must have
attracted many others besides
me to become developmental
biologists. Of my own vintage,
Tokindo Okada (Kyoto) and Lauri
Saxen (Helsinki) have done highly
distinguished work, written
excellent books, and given a
huge amount of time through
organizing meetings and editing
journals to promote
developmental biology at an
international level.
Do you like to take time off
from the laboratory? I have
found that my mind works best
with exercise and obligatory
diversion from the lab. Hence
mountain climbing, skiing, ice
skating, tennis, squash are all
well worth the time and
concentration required. My
doctor advises me that dancing,
listening to mediaeval music and
playing with small dogs are
particularly bad for me.
What do you regard as the
greatest hindrances for
science? Home Office rules and
laboratory inspectors. I believe
that, generally speaking, these
have no interest whatever in the
perceived hazard (risk), which is
usually non-existent. For
example, laboratory amounts of
radioactivity are far below any
clinically effective level (patients
are given 1010 dpm of I131 for
hyperthyroidism). The number of
air changes per day in a mouse
room, or the humidity of the air in
a frog room housing completely
aquatic Xenopus, are wholly
unrelated to the natural
conditions in which animals live.
There is not the slightest
possibility that anyone could
obtain a laboratory licence to go
fishing; and what about garden
centres that sell children animals
that will almost always die of
starvation or neglect a few days
later? Filling out forms and
keeping records doesn’t do any
good for animal welfare or
human health.
Do you have any views on
ethics? Human cloning is a non-
issue in my view: if you want to
clone a human there are plenty of
third world countries without
rules. Likewise, an early human
embryo cannot be regarded as a
potential human being — it has
no possibility of becoming a
human without implantation. It
seems to me immoral to legislate
against the use of early human
embryos by scientists who do
their best to find ways of
reducing unnecessary suffering.
In the early days of in vitro
fertilization pioneers met with
similar hostility.
What do you think about
scientific publishing? Surely
what we all want is the efficient
handling of submitted papers,
and there are some journals and
editors that excel in this respect.
I regret that many major journals
in biology are owned by
commercial companies:
scientists do the work, referee
the papers and buy the journals
— but the profits go to non-
scientific organizations. A good
counter example is the Company
of Biologists, which owns three
highly regarded journals, and all
of the profits go back into
science as contributions to
scientific societies, meetings,
student travel, and so on.
Is teaching a hindrance or
help in research? I have
switched from one to another. In
fact, you might say I have never
managed to hold the same job
down for more than about 10
years. I have always found
teaching painful, but have no
doubt that, in moderation, it can
be very beneficial, even for those
in full-time research
appointments.
Do you have any advice to
those starting their careers? A
number of my contemporaries, at
an early stage, were extremely
clever, erudite, with brilliant
powers of exposition, but were
seduced into tasty administrative
positions. So they had less (or
no) time for experiments, built
large groups, and were forced to
be quicker off the mark than
competitors in taking up the
latest technology discovered by
others. Luckily I was rejected for
nearly all administrative roles for
which my name was put forward.
If someone wants to make a
rewarding career in which they
have contributed something truly
innovative that wouldn’t have
happened without them, my
suggestion is to keep active at
the bench. It’s much more
satisfying to do something
innovative yourself, than be told
about it by a colleague.
Do you have any scientific
ambitions? I would love to see,
in my life time, an understanding
of, and ability to control, cell
differentiation. It must be
possible, theoretically, to derive
any one kind of differentiated cell
from another, and hence to
achieve the practical benefit of
cell replacement as a
consequence of basic scientific
research. Another problem that
has fascinated me since early
childhood is lepidopteran colour
patterns. These are clearly
genetically controlled, but
mutations can’t make subtle
changes to colour patterns, and
non-genetic mechanisms must
surely be a key to the problem.
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